Healthcare ❯ Pharmaceuticals ❯ Drug Regulation
GLP-1 Drug Claims Product Recall
The action marks an escalation of a months-long campaign to police deceptive direct-to-consumer marketing of unapproved compounded versions of popular weight-loss and diabetes medications.
